Phase Ib Multicenter Study Of Trastuzumab Deruxtecan (T-Dxd) And Immunotherapy With Or Without Chemotherapy In First-Line Treatment Of Patients (Pts) With Advanced Or Metastatic Nonsquamous Non-Small Cell Lung Cancer (Nsclc) And Her2 Overexpression (Oe): Destiny-Lung03
Trastuzumab Deruxtecan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase Ib Multicenter Study Of Trastuzumab Deruxtecan (T-Dxd) And Immunotherapy With Or Without Chemotherapy In First-Line Treatment Of Patients (Pts) With Advanced Or Metastatic Nonsquamous Non-Small Cell Lung Cancer (Nsclc) And Her2 Overexpression (Oe): Destiny-Lung03 ### Output: Trastuzumab Deruxtecan